Induction of bone repair in rat calvarial defects using a combination of hydroxyapatite with phosphatidylserine liposomes
Source abstract
Abstract
Phosphatidylserine (PS)―normally present on the inner leaflet of the plasma membrane―translocates to the outer leaflet at an early stage of apoptosis. PS-containing liposomes (PSLs) can mimic the effect of apoptotic cells in inducing the secretion of prostaglandin E2 from phagocytes and inhibiting the maturation of dendritic cells and osteoclast precursors. The present study attempted to evaluate the effect of calcium phosphate (in the form of hydroxyapatite [HAP]) in the presence or absence of PSLs for repair of rat calvarial bone defects. The defects, each 5 mm in diameter, were created in the calvaria parietal bone of 8-week-old Wistar rats and subjected to one of the following treatments: no augmentation (Sham), HAP alone, or a mixture of HAP and PSL (HAP+PSL). Micro-computed tomography data showed that the HAP+PSL complexes promoted greater bone regeneration in comparison with either the Sham procedure or HAP alone at 4 and 8 weeks after implantation. The regeneration of calvarial bone defects induced by PSLs was mediated partly through upregulation of the osteogenic marker Alkaline Phosphatase, Type I collagen, osteocalcin, Runx2, and Osterix mRNAs. These data are the first to show that PSLs can influence bone regeneration by regulating osteoblast differentiation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Phagocytosis and Immune Regulation · Cell death mechanisms and regulation · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Section of Operative Dentistry and Endodontology, Fukuoka Dental College
Section of Molecular Cell Biology and Oral Anatomy, Fukuoka Dental College
Departments of Aging Science and Pharmacology, Faculty of Dental Science, Kyushu University
Funding
Ministry of Education, Culture, Sports, Science and Technology
References (25)
Show source-provided references
1. 1. Wu Z, Ma HM, Kukita T, Nakanishi Y, Nakanishi H (2010) Phosphatidylserine-containing liposomes inhibit the differentiation of osteoclasts and trabecular bone loss. J Immnunol 184, 3191-3201.10.4049/jimmunol.0803609 ↗
2. 2. Henson PM, Bratton DL, Fadok VA (2001) The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 8, 627-633.10.1038/35085094 ↗
3. 3. Ma HM, Wu Z, Nakanishi H (2011) Phosphatidylserine-containing liposomes suppress inflammatory bone loss by ameliorating the cytokine imbalance provoked by infiltrated macrophages. Lab Invest 91, 921-931.10.1038/labinvest.2011.54 ↗
4. 4. Wu Z, Nakanishi H (2006) Phosphatidylserine-containing liposomes: potential pharmacological interventions against inflammatory and immune diseases through the production of prostaglandin E2 after uptake by myeloid derived phagocytes. Arch Immunol Ther Exp (2011) 59, 195-201.10.1007/s00005-011-0123-4 ↗
5. 5. Zhang J, Fujii S, Wu Z, Hashioka S, Tanaka Y, Shiratsuchi A et al. (2006) Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia. J Neuroimmunol 172, 112-120.10.1016/j.jneuroim.2005.11.008 ↗
6. 6. Shinozaki Y, Yanagi T, Yamaguchi Y, Kido H, Fukushima T (2013) Osteogenic evaluation of DNA/protamine complex paste in rat cranial defects. J Hard Tissue Biol 22, 401-408.10.2485/jhtb.22.401 ↗
7. 7. Rizzi SC, Heath DJ, Coombes AG, Bock N, Textor M, Downes S (2001) Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts. J Biomed Mater Res 55, 475-486.10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q ↗
8. 8. Toda M, Ohno J, Shinozaki Y, Ozaki M, Fukushima T (2014) Osteogenic potential for replacing cells in rat cranial defects implanted with a DNA/protamine complex paste. Bone 67, 237-245.10.1016/j.bone.2014.07.018 ↗
9. 9. Tsuruga E, Takita H, Itoh H, Wakisaka Y, Kuboki Y (1997) Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 121, 317-324.10.1093/oxfordjournals.jbchem.a021589 ↗
10. 10. Ferreira GR, Cestari TM, Granjeiro JM, Taga R (2004) Lack of repair of rat skull critical size defect treated with bovine morphometric protein bound to microgranular bioabsorbable hydroxyapatite. Braz Dent J 15, 175-180.10.1590/S0103-64402004000300002 ↗
11. 11. Dong X, Wang Q, Wu T, Pan H (2007) Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001)surface. Biophys J 93, 750-759.10.1529/biophysj.106.103168 ↗
12. 12. Kim SS, Gwak SJ, Kim BS (2008) Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2. J Biomed Mater Res A 87, 245-253.10.1002/jbm.a.31782 ↗
13. 13. Li J, Hong J, Zheng Q, Guo X, Lan S, Cui F et al. (2011) Repair of rat cranial bone defects with nHAC/PLLA and BMP-2-related peptide or rhBMP-2. J Orthop Res 29, 1745-1752.10.1002/jor.21439 ↗
14. 14. Kutikov AB, Song J (2013) An amphiphilic degradable polymer/hydroxyapatite composite with enhanced handling characteristics promotes osteogenic gene expression in bone marrow stromal cells. Acta Biomater 9, 8354-8364.10.1016/j.actbio.2013.06.013 ↗
15. 15. Notodihardjo FZ, Kakudo N, Kushida S, Suzuki K, Kusumoto K (2012) Bone regeneration with BMP-2 and hydroxyapatite in critical-size calvarial defects in rats. J Craniomaxillofac Surg 40, 287-291.10.1016/j.jcms.2011.04.008 ↗
16. 16. Wu D, Chen X, Chen T, Ding C, Wu W, Li J (2015) Substrate-anchored and degradation-sensitive anti-inflammatory coatings for implant materials. Sci Rep 5, 11105.10.1038/srep11105 ↗
17. 17. Carragee EJ, Hurwitz EL, Weiner BK (2011) A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11, 471-491.10.1016/j.spinee.2011.04.023 ↗
18. 18. Mizuta N, Hattori K, Suzawa Y, Iwai S, Matsumoto T, Tadokoro M et al. (2013) Mesenchymal stromal cells improve the osteogenic capabilities of mineralized agarose gels in a rat full-thickness cranial defect model. J Tissue Eng Regen Med 7, 51-60.10.1002/term.495 ↗
19. 19. Itagaki T, Honma T, Takahashi I, Echigo S, Sasano Y (2008) Quantitative analysis and localization of mRNA transcripts of type I collagen, osteocalcin, MMP 2, MMP 8, and MMP 13 during bone healing in a rat calvarial experimental defect model. Anat Rec (Hoboken) 291, 1038-1046.10.1002/ar.20717 ↗
20. 20. Honma T, Itagaki T, Nakamura M, Kamakura S, Takahashi I, Echigo S et al. (2008) Bone formation in rat calvaria ceases within a limited period regardless of completion of defect repair. Oral Dis 14, 457-464.10.1111/j.1601-0825.2007.01401.x ↗
21. 21. Mizuno M, Shindo M, Kobayashi D, Tsuruga E, Amemiya A, Kuboki Y (1997) Osteogenesis by bone marrow stromal cells maintained on type I collagen matrix gels in vivo. Bone 20, 101-107.10.1016/S8756-3282(96)00349-3 ↗
22. 22. Wlodarski KH (1989) Normal and heterotopic periosteum. Clin Orthop Relat Res 241, 265-277.
23. 23. Joyce ME, Roberts AB, Sporn MB, Bolander ME (1990) Transforming growth factor-beta and the initiation of chon-drogenesis and osteogenesis in the rat femur. J Cell Biol 110, 2195-2207.10.1083/jcb.110.6.2195 ↗
24. 24. Takagi K, Urist MR (1982) The reaction of the dura to bone mor- phogeneic protein (BMP) in repair of skull defects. Ann Surg 196, 100-109.10.1097/00000658-198207000-00020 ↗
25. 25. Yu JC, McClintock JS, Gannon F, Gao XX, Mobasser JP, Sharawy M (1997) Regional differences of dura osteoinduction: squa- mous dura induces osteogenesis, sutural dura induces chondrogenesis and osteogenesis. Plast Reconstr Surg 100, 23-31.10.1097/00006534-199707000-00005 ↗